Cullinan Therapeutics Inc
CGEM
NASDAQ
Biotechnology
$20.34
USD
+0.70 (+3.56%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.26B
Volume 565.5K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
VOR | Vor Biopharma Inc | $1.25B | - | - | - | |
MGTX | MeiraGTx Holdings PLC | $1.22B | - | +131.1% | - | |
CGEM | Cullinan Therapeutics Inc | $1.18B | - | - | - | |
REPL | Replimune Group Inc | $1.15B | - | - | - | |
CRVS | Corvus Pharmaceuticals Inc | $1.14B | - | - | - | |
SVRA | Savara Inc | $1.08B | - | - | - | |
ODTX | Odyssey Therapeutics Inc | $1.07B | - | -19.0% | - | |
OLMA | Olema Pharmaceuticals Inc | $1.04B | - | - | - | |
ARDX | Ardelyx Inc | $989.27M | - | +16.8% | - |
Top Peer by Growth
Inhibrx Biosciences Inc
+550.0% YoY Revenue
Best 1-Year Return
Inhibrx Biosciences Inc
+348.7% Return